RALBP1 and Hyperglycemia: A corollary to this hypothesis is that medications commonly used to treat hyperglycemia and hypertriglyceridemia should fail to function in RLIP76−/− mice if RLIP76 is indeed necessary for the clinical manifestations of oxidative-stress characteristic of MSy and T2D.